351
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Donor-matched comparison of chondrogenic progenitors resident in human infrapatellar fat pad, synovium, and periosteum - implications for cartilage repair

ORCID Icon, , , , , , & ORCID Icon show all
Pages 597-610 | Received 25 Oct 2018, Accepted 04 Apr 2019, Published online: 14 May 2019
 

ABSTRACT

Purpose: There is a clinical need to better characterize tissue sources being used for stem cell therapies. This study focuses on comparison of cells and connective tissue progenitors (CTPs) derived from native human infrapatellar fatpad (IPFP), synovium (SYN), and periosteum (PERI).

Materials and Methods: IPFP, SYN, PERI were harvested from twenty-eight patients undergoing arthroplasty. CTPs were quantitatively characterized using automated colony-forming-unit assay to compare total nucleated cell concentration—[Cell], cells/mg; prevalence-(PCTP), CTPs/million nucleated cells; CTP concentration—[CTP], CTPs/mg; proliferation and differentiation potential; and correlate outcomes with patient’s age and gender.

Results: [Cell] did not differ between IPFP, SYN, and PERI. PCTP was influenced by age and gender: patients >60 years, IPFP and SYN had higher PCTP than PERI (p < 0.001) and females had higher PCTP in IPFP (p < 0.001) and SYN (p = 0.001) than PERI. [CTP] was influenced by age: patients <50 years, SYN (p = 0.0165) and PERI (p < 0.001) had higher [CTP] than IPFP; patients between 60 and 69 years, SYN (p < 0.001) had higher [CTP] than PERI; patients >70 years, IPFP (p = 0.006) had higher [CTP] than PERI. In patients >60 years, proliferation potential of CTPs differed significantly (SYN>IPFP>PERI); however, differentiation potentials were comparable between all three tissue sources.

Conclusion: SYN and IPFP may serve as a preferred tissue source for patients >60 years, and PERI along with SYN and IPFP may serve as a preferred tissue source for patients <60 years for cartilage repair. However, the heterogeneity among the CTPs in any given tissue source suggests performance-based selection might be useful to optimize cell-sourcing strategies to improve efficacy of cellular therapies for cartilage repair.

Disclosure statement

No potential conflict of interest was reported by the authors.

Author contributions

  1. Conception and Study design: GFM, VPM, CB.

  2. Acquisition of data, data analyses: VPM, WB, CB, GFM.

  3. Statistical analysis and interpretation: NO, VPM, GFM.

  4. Writing and Revising: VPM, NP, CB, WB, RJM, VL, GFM.

Additional information

Funding

This work was supported by National Institutes of Health grant [R01AR063733] awarded to GFM.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.